首页> 外国专利> 2 - amino - benzoxazole sulfonamide inhibitors of wide spectrum of HIV Protease, Pharmaceutical Composition and Method for inhibiting in vitro retroviral Replication, and use of these compounds in the manufacture of medicinal products

2 - amino - benzoxazole sulfonamide inhibitors of wide spectrum of HIV Protease, Pharmaceutical Composition and Method for inhibiting in vitro retroviral Replication, and use of these compounds in the manufacture of medicinal products

机译:HIV蛋白酶的广谱2-氨基-苯并恶唑磺酰胺抑制剂,药物组合物和抑制体外逆转录病毒复制的方法,以及这些化合物在生产医药产品中的用途

摘要

2-amine-benzo-p-sulfosamide (1),Nitrous oxide, salt, stereoisomer form, racemic mixture, by-product, ester or its metabolite, wherein R1 and R8 are independent,Hydrogen, C1-6 tar, c12-6 alquenilo C1-6, arilalquilo C1-6, cycloquilo c3-7, cycloquil c3-7, cycloquil C1-6, arilo, het1-tar C1-6, het2 or het2-tar C1-6; R1 may also be a (r11a) (r11b) N-C (r10a) (r10b) - ch9 - wherein R9, r10a and 10r10b are independent of each other,hydrogen, C1-4 alkyloxycarbonyl, carboxyl, aminocarbonyl, mono- or di (C1-4 alkyl) aminocarbonyl, C3-7 cycloalkyl, C2-6 alkenyl, C2-6 alkynyl, or C1-4 alkyl optionally substituted with aryl, Het1, Het2, C3-7 cycloalkyl, C1-4 alkyloxycarbonyl, carboxyl, aminocarbonyl, mono- or di (C1-4 alkyl) aminocarbonyl, aminosulfonyl, C1-4S (O) t alkyl, hydroxy, cyano, halogen or optionally mono- or amino disubstituted, where the substituents are selected, independently of each other,from the group consisting of C1-4 alkyl, aryl, C1-4 arylalkyl, C3-7 cycloalkyl, C3-7 cycloalkyl C1-4 alkyl, Het1, Het2, Het1-C1-4 alkyl and Het2-C1-4 alkyl; whereby R9, R10a and the carbon atoms to which they are attached can also form a C3-7 cycloalkyl radical; when L is -O-C1-6-C-alkanediyl (= O) - or -NR8-C1-6-C-alkanediyl (= O) -,then R9 can also be oxo; R11a is hydrogen, C2-6 alkenyl, C2-6 alkynyl, C3-7 cycloalkyl, aryl, optionally mono- or disubstituted aminocarbonyl, optionally mono- or disubstituted C1-4 -alkylcarbonyloxy, C1-4 alkyloxycarbonyl, aryloxycarbonyl, Het1-oxycarbonyl, Het2 -oxycarbonyl, C 1-4 aryloxycarbonylalkyl, C 1-4 aryl alkoxycarbonyl, C 1-7 alkylcarbonyl, C 3-7 cycloalkylcarbonyl, C 3-7 cycloalkylcarbonyloxy, C 1-4 cycloalkylcarbonyloxy, C 1-4 alkylcarbonyloxy, C1-4, arylcarbonyloxy, aryloxycarbonyloxy, Het1-carbonyl, Het1-carbonyloxy, Het1-C1-4 alkyloxycarbonyl, Het2-carbonyloxy,Het2-c1-4 C1-4, het2-c1-4, C1-4, C1-4 or C1-4 tar is optionally replaced with ariloxi, ariloxi, het2, halogen or hydroxy; in these substances, the alternatives in the amino group are independently selected,del grupo formado por alquilo C1-4 arilo arilalquilo C1-4 cicloalquilo C3-7 cicloalquil C3-7 alquilo C1-4 Het1 Het2 Het1-alquilo C1-4 y Het2-alquilo C1-4 R11b es hidr geno cicloalquilo C3-7 alquenilo C2 1. From the tar groups of C1-4, arilo, arilalquilo C1-4, cycloquilo c3-7, cycloquil c3-7, cycloquil c3-7, C1-4, het1, het2, het1-c1-4 and het2-c1-4, r11b can be combined with other molecules through a sulfur group; t is independent, 0, 1 or 2; R2 is hydrogen or C1-6; L is - C (= O)-O-C (3DO) --NR8-C (O) -,-O-alkane c1-6-c (= O) -,-Nr8 alkane c1-6-c (= O) -,-S (3DO) 2--O-S (3DO) 2--Nr8-s (= O) 2, wherein group C (= O) or group s (= O) 2 is associated with NR2 fraction; therefore, C1-6 alkane fraction can be replaced by hydroxyl, arilo, het1 and het2; R3 is C1-6, arilo, cyclo-7, cyclo-7, cycloquil c3-7 C1-4 or arilalquilo C1-4; R4 is C14, carbon chloride, hydrocarbon, C14. 1. Tar of carbamate, thyroid carbamate, thyroid c3-7, acrylonitrile c2-6 or C1-6, which is selectively replaced by one or more alternative substitutes;Substitutes consisting of arilo, het1, het2, cycloquilo c3-7, C1-4, C1-4, carboxyl, aminobonilo, mono-o di (C1-4 tar) aminobenzene, aminosulfonilo, C1-4 tar s (= O) t, hydroxi, Ciano, halogen and any single monkey - or discustuido are selected independently,A group consisting of C1-4, arilo, arilalquilo C1-4, cichoil quilo c3-7, cichoil quil c3-7, C1-4 tar, het1, het2, het1-c1-4 and het2-tar C1-4; R5 is hydrogen or C1-6 tar; R6 is hydrogen or C1-6 tar; pharmaceutical composition, "In vitro" inhibition of antiretroviral replication and use of these compounds in drug manufacture. Formula compound (1) is used as an inhibitor of asarctic proteome, especially HIV proteome, so it has an inhibitory effect on HIV.
机译:2-胺-苯并-对-磺酰胺(1),一氧化二氮,盐,立体异构体形式,外消旋混合物,副产物,酯或其代谢物,其中R1和R8独立,氢,C1-6焦油,c12-6 Alquenilo C1-6,阿里洛基洛C1-6,cycloquilo c3-7,cycloquil c3-7,cycloquil C1-6,arilo,het1-tar C1-6,het2或het2-tar C1-6; R1也可以是(r11a)(r11b)NC(r10a)(r10b)-ch9-其中R9,r10a和10r10b彼此独立,氢,C1-4烷氧羰基,羧基,氨基羰基,单或双(C1 -4烷基)氨基羰基,C3-7环烷基,C2-6烯基,C2-6炔基或任选地被芳基,Het1,Het2,C3-7环烷基,C1-4烷氧羰基,羧基,氨基羰基取代的C1-4烷基-或二(C1-4烷基)氨基羰基,氨基磺酰基,C1-4S(O)t烷基,羟基,氰基,卤素或任选地单或氨基二取代的基团,其中取代基彼此独立地选自: C1-4烷基,芳基,C1-4芳基烷基,C3-7环烷基,C3-7环烷基C1-4烷基,Het1,Het2,Het1-C1-4烷基和Het2-C1-4烷基。其中R9,R10a和它们所连接的碳原子也可以形成C3-7环烷基。当L为-O-C1-6-C-链烷二基(= O)-或-NR8-C1-6-C-链烷二基(= O)时,R9也可以为氧代。 R 11a是氢,C 2-6烯基,C 2-6炔基,C 3-7环烷基,芳基,任选地单或二取代的氨基羰基,任选地单或二取代的C 1-4烷基羰基氧基,C 1-4烷氧基羰基,芳氧基羰基,Het1-氧羰基, Het2-氧基羰基,C 1-4芳氧基羰基烷基,C 1-4芳基烷氧基羰基,C 1-7烷基羰基,C 3-7环烷基羰基,C 3-7环烷基羰氧基,C 1-4环烷基羰氧基,C 1-4烷基羰氧基,C1-4 ,芳基羰基氧基,芳基氧基羰基氧基,Het1-羰基,Het1-羰基氧基,Het1-C1-4烷氧基羰基,Het2-羰基氧基,Het2-c1-4 C1-4,het2-c1-4,C1-4,C1-4或C1-4焦油可选地被ariloxi,ariloxi,het2,卤素或羟基取代;在这些物质中,氨基中的替代基团是独立选择的,如C1-4阿里洛arilalquilo C1-4 cicloalquilo C3-7 cicloalquil C3-7 alquilo C1-4 Het1 Het2 Het1-alquilo C1-4和Het2- alquilo C1-4 R11b es hidr genlo cicloalquilo C3-7 alquenilo C2 1.来自tar组的C1-4,arilo,alilalquilo C1-4,cycloquilo c3-7,cycloquil c3-7,cycloquil c3-7,C1-4 ,het1,het2,het1-c1-4和het2-c1-4,r11b可以通过硫基与其他分子结合; t独立,为0、1或2; R 2为氢或C 1-6; L为-C(= O)-OC(3DO)-NR8-C(O)-,-O-烷烃c1-6-c(= O)-,-Nr8烷烃c1-6-c(= O) -,-S(3DO)2--OS(3DO)2--Nr8-s(= O)2,其中基团C(= O)或基团s(= O)2与NR2分数相关;因此,C 1-6烷烃馏分可以被羟基,芳基,het1和het2取代; R3为C1-6,芳基,环7,环7,环基c3-7C1-4或阿里基基洛C1-4; R 4是C 14,氯化碳,烃,C 14。 1.氨基甲酸酯,甲状腺氨基甲酸酯,甲状腺c3-7,丙烯腈c2-6或C1-6的焦油,可选择性地用一种或多种替代品替代;取代基包括arilo,het1,het2,cycloquilo c3-7,C1- 4,C1-4,羧基,羧基,氨基bonilo,单邻二(C1-4 tar)氨基苯,氨基磺酰,C1-4 tar s(= O)t,水解,Ciano,卤素和任何单个猴子-或discustuido -C1-4,arilo,alilalquilo C1-4,黄芪quilo c3-7,cichoil quil c3-7,C1-4 tar,het1,het2,het1-c1-4和het2-tar C1-4组成的组; R5是氢或C1-6焦油; R6是氢或C1-6焦油;药物组合物,“体外”抑制抗逆转录病毒复制,以及这些化合物在药物生产中的用途。式(1)化合物被用作骨蛋白特别是HIV蛋白质组的抑制剂,因此对HIV具有抑制作用。

著录项

  • 公开/公告号AR035970A1

    专利类型

  • 公开/公告日2004-07-28

    原文格式PDF

  • 申请/专利权人 TIBOTEC PHARMACEUTICALS LTD.;

    申请/专利号AR2002P101722

  • 发明设计人

    申请日2002-05-10

  • 分类号C07D413/12;C07D413/14;C07D417/12;C07D417/14;C07D498/04;C07D493/04;C07D491/04;C07D513/04;C07D263/58;A61K31/423;

  • 国家 AR

  • 入库时间 2022-08-21 23:12:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号